Skip to main content

Spectrum: Autism Research News

Tag: glutamate

March 2015

Treatment eases fragile X symptoms in flies, mice

by  /  9 March 2015

Blocking an enzyme involved in learning and memory corrects brain abnormalities and improves memory in fly and mouse models of fragile X syndrome.

Comments
November 2014

Growth factor rescues neurons made from boys with Rett

by  /  18 November 2014

Neurons derived from the skin cells of boys with Rett syndrome can help screen potential treatments for the disorder, suggest unpublished results presented yesterday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

Comments

Non-starring cells may be key in fragile X syndrome

by  /  17 November 2014

Mice missing the FMR1 gene only in star-shaped brain cells called astrocytes recapitulate key features of fragile X syndrome. Researchers presented the unpublished results today at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

Comments

Sensors shed light on levels of chemical messengers in mice

by  /  12 November 2014

Cells modified to carry fluorescent sensors can help researchers detect the levels of various chemical messengers in the brains of living mice.

Comments
October 2014

Gene-editing tool can erase proteins at neuronal junctions

by  /  1 October 2014

CRISPR, the genetic tool that cuts and pastes DNA, can eliminate specific proteins at the points of connection between neurons. The method, described 3 September in Neuron, could help researchers determine the role of those proteins in brain signaling.

Comments
July 2014

Autism gene affects brain function early in development

by  /  28 July 2014

Mutations in a gene linked to intellectual disability and sometimes autism may lead to a permanent boost in brain activity, according to a study published 18 June in Neuron.

Comments
June 2014

Molecular mechanisms: Fragile X gene tied to cocaine effects

by  /  24 June 2014

The protein missing in fragile X syndrome is necessary for mice to respond to the stimulant cocaine, according to a study published 7 May in Neuron.

Comments
May 2014

Drug company halts tests of fragile X drug

by  /  6 May 2014

Following disappointing results from two clinical trials, the Swiss pharmaceutical company Novartis announced on 24 April that it will stop development of a drug candidate for fragile X syndrome.

Comments
December 2013

Understanding contradictory connectivity reports in autism

by ,  /  10 December 2013

Studies at the level of neural circuits are needed to better understand the importance of both increased and decreased connectivity between different regions in the autism brain, say John Rubenstein and Vikaas Sohal.

Comments
November 2013

Neurons made directly from skin cells model autism mutations

by  /  27 November 2013

Skin cells taken from mice with an autism-linked mutation and transformed directly into neurons have the same properties as neurons from the brains of these mice. The study, published 8 October in Proceedings of the National Academy of Sciences, validates an efficient technique to study disease-linked mutations.

Comments